Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology

[1]  M. Hudgens,et al.  Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). , 2012, Gynecologic oncology.

[2]  S. Wacholder,et al.  Human papillomavirus testing in the prevention of cervical cancer. , 2011, Journal of the National Cancer Institute.

[3]  M. Reuschenbach,et al.  Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology , 2010, Journal of Clinical Microbiology.

[4]  K. Lakshmaiah,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[5]  A. Longatto-Filho,et al.  Value of Conventional Pap Smear, Liquid-Based Cytology, Visual Inspection and Human Papillomavirus Testing as Optional Screening Tools Among Latin American Women < 35 and = 35 Years of Age , 2008, Acta Cytologica.

[6]  Marc Arbyn,et al.  Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India , 2008, International journal of cancer.

[7]  Marc Arbyn,et al.  Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis , 2008, Obstetrics and gynecology.

[8]  S. Walter,et al.  Assessing the gain in diagnostic performance when two visual inspection methods are combined for cervical cancer prevention , 2007, Journal of medical screening.

[9]  J. Cuzick,et al.  Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial , 2007, BMJ : British Medical Journal.

[10]  Attila Lorincz,et al.  Visual inspection as a cervical cancer screening method in a primary health care setting in Africa , 2006, International journal of cancer.

[11]  J. Cuzick,et al.  Overview of the European and North American studies on HPV testing in primary cervical cancer screening , 2006, International journal of cancer.

[12]  S. Tatti,et al.  Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. , 2006, Journal of medical screening.

[13]  L. Irwig,et al.  Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review , 2006, The Lancet.

[14]  D. Parkin,et al.  A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India , 2005, International journal of cancer.

[15]  S. Tatti,et al.  Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. , 2005, Anticancer research.

[16]  S. Tatti,et al.  Conventional Pap Smear and Liquid-Based Cytology as Screening Tools in Low-Resource Settings in Latin America , 2005, Acta Cytologica.

[17]  L. Gaffikin,et al.  Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening , 2005, Cancer Causes & Control.

[18]  M. Temmerman,et al.  Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA‐PCR testing and cervicography , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[19]  D. Parkin,et al.  Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India , 2003, International journal of cancer.

[20]  L. Gaffikin,et al.  Performance of Visual Inspection With Acetic Acid for Cervical Cancer Screening: A Qualitative Summary of Evidence to Date , 2003, Obstetrical & gynecological survey.

[21]  G. Parham,et al.  A comparison of four screening methods for cervical neoplasia in a developing country. , 2003, American journal of obstetrics and gynecology.

[22]  K. Syrjänen,et al.  Combined Pap Smear, Cervicography and HPV DNA Testing in the Detection of Cervical Intraepithelial Neoplasia and Cancer , 2000, Acta Cytologica.

[23]  L. Mango,et al.  Cervicography screening for cervical cancer among 8460 women in a high-risk population. , 1999, American journal of obstetrics and gynecology.

[24]  D. Hertens,et al.  A multicentre study comparing cervicography and cytology in the detection of cervical intraepithelial neoplasia , 1998, British journal of obstetrics and gynaecology.

[25]  I. Ramzy,et al.  Increased Detection of Epithelial Cell Abnormalities by Liquid-Based Gynecologic Cytology Preparations , 1998, Acta Cytologica.

[26]  L Irwig,et al.  Meta-analysis of Pap test accuracy. , 1995, American journal of epidemiology.

[27]  S. Tatti,et al.  Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. , 2008, European journal of gynaecological oncology.

[28]  W. Prendiville,et al.  Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. , 2007, Gynecologic oncology.

[29]  Evan R. Myers,et al.  Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review , 2001 .